Alembic Pharma share price surged after the USFDA issued establishment inspection report (EIR) for the inspection carried out ...
Paliperidone extended-release tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg have an estimated market size of $48 million for 12 ...
Alembic Pharmaceuticals oral solid formulation facility (F-1) located in Panelav, Gujarat received establishment inspection report (EIR) from United States Food and Drug Administration (USFDA), which ...
The approved strengths are 1.5 mg, 3 mg, 6 mg, and 9 mg, and the product is therapeutically equivalent to Janssen's Invega.
Vadodara: Alembic Pharma has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US ...
Alembic Pharma gets US FDA approval for paliperidone ER tablets: Our Bureau, Bengaluru Monday, September 30, 2024, 11:30 Hrs [IST] Alembic Pharmaceuticals has received final appro ...
Mumbai: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug ...
Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated ...
Alembic Pharmaceuticals receives FDA approval for Paliperidone Tablets, trading at ₹1,179.95 on NSE, expanding its global ...
Alembic Pharma Ltd. has received an establishment inspection report from the US Food and Drug Administration for its facility in Panelav, Gujarat. The EIR was issued post the last inspection of the ...